These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 28225306

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Growth hormone therapy alone or in combination with gonadotropin-releasing hormone analog therapy to improve the height deficit in children with congenital adrenal hyperplasia.
    Quintos JB, Vogiatzi MG, Harbison MD, New MI.
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1511-7. PubMed ID: 11297576
    [Abstract] [Full Text] [Related]

  • 24. Patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency can achieve their target height: the Leipzig experience.
    Hoepffner W, Kaufhold A, Willgerodt H, Keller E.
    Horm Res; 2008 Apr; 70(1):42-50. PubMed ID: 18493149
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Impact of Newborn Screening on Adult Height in Patients With Congenital Adrenal Hyperplasia (CAH).
    Hoyer-Kuhn H, Eckert AJ, Binder G, Bonfig W, Dübbers A, Riedl S, Woelfle J, Dörr HG, Holl RW.
    J Clin Endocrinol Metab; 2023 Oct 18; 108(11):e1199-e1204. PubMed ID: 37256841
    [Abstract] [Full Text] [Related]

  • 31. Blood pressure in children and adolescents with congenital adrenal hyperplasia (21-hydroxylase deficiency): a preliminary report.
    Roche EF, Charmandari E, Dattani MT, Hindmarsh PC.
    Clin Endocrinol (Oxf); 2003 May 18; 58(5):589-96. PubMed ID: 12699440
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Growth patterns and outcomes in congenital adrenal hyperplasia; effect of chronic treatment regimens.
    Rasat R, Espiner EA, Abbott GD.
    N Z Med J; 1995 Aug 11; 108(1005):311-4. PubMed ID: 7644165
    [Abstract] [Full Text] [Related]

  • 35. Growth and pubertal characteristics in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Trinh L, Nimkarn S, New MI, Lin-Su K.
    J Pediatr Endocrinol Metab; 2007 Aug 11; 20(8):883-91. PubMed ID: 17937061
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. A Prospective Study of Children Aged 0-8 Years with CAH and Adrenal Insufficiency Treated with Hydrocortisone Granules.
    Neumann U, Braune K, Whitaker MJ, Wiegand S, Krude H, Porter J, Digweed D, Voet B, Ross RJM, Blankenstein O.
    J Clin Endocrinol Metab; 2021 Mar 08; 106(3):e1433-e1440. PubMed ID: 32888021
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Growth and Treatment in Congenital Adrenal Hyperplasia: An Observational Study from Diagnosis to Final Height.
    Gidlöf S, Hogling DE, Lönnberg H, Ritzén M, Lajic S, Nordenström A.
    Horm Res Paediatr; 2024 Mar 08; 97(5):445-455. PubMed ID: 38016434
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.